Peginterferon-α-2a (40kD) plus ribavirin: a new treatment option takes flight in chronic hepatitis C Drugs and Profile Reports 11 December 2012 Pages: 1 - 4
Dutasteride: profile report J. Curtis NickelGerald L. Andriole Drugs and Profile Reports 11 December 2012 Pages: 5 - 7
Controversy still abounds over the safest and most effective treatment of Graves’ disease in children Disease Management 11 December 2012 Pages: 7 - 10
Emollients and keratolytics remain the mainstay of therapy for patients with ichthyosis Disease Management 11 December 2012 Pages: 11 - 15
Zopiclone, zolpidem and zaleplon: get your ‘zzz’s’ without affecting performance the next day Disease Management 11 December 2012 Pages: 16 - 18
Cannabinoids courting attention because of their potential in CNS disorders Disease Management 11 December 2012 Pages: 19 - 22
First reports of adverse drug reactions (ADRs) in recent weeks Drug Reactions and Interactions 11 December 2012 Pages: 23 - 24
Racial differences in response to drug therapy for heart failure have implications in approaching patient treatment Practical Issues and Updates 11 December 2012 Pages: 25 - 26
